BBA
FPRX

Baker Bros. Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Baker Bros. Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-668,000
Closed -$11.4M – 138
2020
Q4 		$11.4M Buy
+668,000
New +$8.37M 0.04% 70
2018
Q1 		– Sell
-19,247
Closed -$422K – 123
2017
Q4 		$422K Hold
19,247
– – ﹤0.01% 117
2017
Q3 		$787K Hold
19,247
– – 0.01% 109
2017
Q2 		$580K Hold
19,247
– – 0.01% 111
2017
Q1 		$696K Hold
19,247
– – 0.01% 106
2016
Q4 		$964K Hold
19,247
– – 0.01% 109
2016
Q3 		$1.01M Hold
19,247
– – 0.01% 112
2016
Q2 		$796K Hold
19,247
– – 0.01% 121
2016
Q1 		$782K Hold
19,247
– – 0.01% 119
2015
Q4 		$799K Hold
19,247
– – 0.01% 123
2015
Q3 		$296K Hold
19,247
– – ﹤0.01% 130
2015
Q2 		$478K Hold
19,247
– – ﹤0.01% 122
2015
Q1 		$440K Sell
19,247
-576
-3% -$14.5K ﹤0.01% 124
2014
Q4 		$535K Hold
19,823
– – 0.01% 116
2014
Q3 		$233K Hold
19,823
– – ﹤0.01% 106
2014
Q2 		$308K Hold
19,823
– – ﹤0.01% 103
2014
Q1 		$390K Hold
19,823
– – 0.01% 105
2013
Q4 		$333K Buy
+19,823
New +$246K ﹤0.01% 92

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Baker Bros. Advisors's FPRX Position: Q1 2021 in Review

Baker Bros. Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 668,000 shares — an estimated $11.4M sold.

Baker Bros. Advisors first reported a position in FPRX in Q4 2013 and held it in 18 quarters. The position peaked at $11.4M in Q4 2020. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Baker Bros. Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 668,000 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $11.4M.
  • Baker Bros. Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 18 quarters.
  • Baker Bros. Advisors's Five Prime Therapeutics, Inc. position peaked at $11.4M in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Baker Bros. Advisors's 13F filing for Q1 2021, filed 17 May 2021.